Microplastics in Medication: Inhalers, Blister Packs & Eye Drops

Last updated: May 25, 2026

Important disclaimer: medication first, microplastics second

Prescribed medications save and improve lives. For people with asthma, heart conditions, diabetes, autoimmune disease, glaucoma, and most other chronic conditions, the medical benefit of taking prescribed medication far outweighs the microplastic exposure risk. Never skip doses or stop a prescription over concerns about microplastic packaging.

This article identifies where exposure exists in pharmaceutical delivery so that patients and clinicians can make informed choices within available alternatives — not to discourage medication.

Where microplastic enters the medication chain

Asthma inhalers: MDI vs DPI

Metered-dose inhalers (MDIs) like Albuterol HFA, Ventolin, and ProAir use a pressurized hydrofluoroalkane (HFA) propellant in a plastic actuator. The plastic contact during actuation and the HFA propellant combination are the primary microplastic concerns.

Dry-powder inhalers (DPIs) like Advair Diskus, Spiriva HandiHaler, and Breo Ellipta deliver medication as a fine powder without propellants. They have less plastic-liquid contact per dose. Ask your pulmonologist whether a DPI is appropriate for your condition.

Some newer eco-conscious MDIs use HFC-152a propellant (lower greenhouse warming) — these don't change the microplastic profile but reduce environmental impact.

Eye drops specifically

Eye drops sit in plastic bottles for months. The cornea and conjunctiva have higher permeability than skin. For frequently-used eye drops (glaucoma patients, dry-eye sufferers using artificial tears multiple times daily), cumulative microplastic exposure may be meaningful. Options:

• Glass-bottled compounded prescriptions — ask your eye doctor if your prescription can be filled at a compounding pharmacy in glass.
• Preservative-free unit-dose vials (single-use plastic ampules) — reduce total plastic-eye contact time per dose since they're used immediately.
• Refresh Optive PF, Systane Hydration PF, TheraTears PF — single-use preservative-free options for dry eye.
• For glaucoma: some prescription medications come in HDPE bottles considered relatively stable; discuss alternatives with your ophthalmologist.

IV bags and DEHP

Hospital IV bags are typically PVC plasticised with DEHP (di-2-ethylhexyl phthalate), an endocrine disruptor. DEHP migrates from the bag into the IV fluid, especially with lipid-containing medications. FDA and EU have flagged this for sensitive populations (premature infants, pregnant women, hemodialysis patients).

DEHP-free alternatives (polyolefin bags, non-DEHP PVC) are increasingly available. If you or a family member needs extended inpatient IV therapy, ask your medical team whether DEHP-free bags are used.

Practical guidance for chronic-illness patients

1. Continue all prescribed medications. Medical benefit far outweighs microplastic concern.
2. Ask about glass-bottled alternatives. Eye drops, liquid medications, some supplements can be glass-bottled.
3. For inhalers, discuss DPI vs MDI with your pulmonologist.
4. For inpatient care, ask about DEHP-free IV bags if you have extended hospitalization.
5. Compensate with reduction elsewhere. The 80% of microplastic exposure that comes from non-medication sources (water, food storage, etc.) is fully controllable. See our 30-day action plan.
6. Skip OTC supplements unless necessary. Vitamins and over-the-counter medications often have more discretion than prescribed drugs — choose glass-bottled supplements where possible.
7. Don't microwave medication. If a topical or liquid medication needs warming, use warm water bath, not microwave.

See related: microplastics in vitamins and supplements, microplastics and thyroid, and microplastics health effects.